ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA)
CUSIP: 29273B302
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,186,300
- Total 13F shares
- 263,961
- Share change
- +132,807
- Total reported value
- $153,035
- Price per share
- $0.58
- Number of holders
- 13
- Value change
- +$71,311
- Number of buys
- 9
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 29273B302?
CUSIP 29273B302 identifies NDRA - ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29273B302:
Top shareholders of NDRA - ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.4%
|
52,183
|
$110,685 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.4%
|
39,812
|
$84,401 | — | 31 Dec 2023 | |
| NewEdge Advisors, LLC |
13F
|
Company |
2.6%
|
31,257
|
$66,261 | — | 31 Dec 2023 | |
| Michael Milos Thornton |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
34,139
|
$56,329 | — | 18 May 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.27%
|
3,227
|
$6,841 | — | 31 Dec 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.25%
|
2,983
|
$6,324 | — | 31 Dec 2023 | |
| VALLEY NATIONAL ADVISERS INC |
13F
|
Company |
0.07%
|
869
|
$1,000 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
332
|
$704 | — | 31 Dec 2023 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.03%
|
329
|
$697 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
103
|
$218 | — | 31 Dec 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
58
|
$123 | — | 31 Dec 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Dec 2023 | |
| Renaud Bertrand Maloberti |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
186,430
|
— | — | 28 Mar 2022 | |
| Francois Roger Michelon |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
69,531
|
— | — | 30 Jan 2023 | |
| Irina Pestrikova |
3/4/5
|
Senior Director, Finance |
—
class O/S missing
|
8,000
|
— | — | 30 Jan 2023 |
Institutional Holders of ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) as of Q1 2024
As of 31 Mar 2024,
ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
263,961 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA SECURITIES, LLC, VANGUARD GROUP INC, JANE STREET GROUP, LLC, Virtu Financial LLC, NewEdge Advisors, LLC, XTX Topco Ltd, Tower Research Capital LLC (TRC), MORGAN STANLEY, and NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
11
Q1 2024 holders
13
Holder diff
2
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.